Uniplan Investment Counsel’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-224,906
Closed -$8.36M 131
2019
Q4
$8.36M Sell
224,906
-9,965
-4% -$355K 0.5% 47
2019
Q3
$8.01M Buy
234,871
+4,226
+2% +$154K 0.5% 48
2019
Q2
$9.48M Buy
230,645
+882
+0.4% +$35K 0.6% 42
2019
Q1
$9.26M Sell
229,763
-22,254
-9% -$891K 0.59% 40
2018
Q4
$10.4M Sell
252,017
-26,715
-10% -$1.11M 0.72% 37
2018
Q3
$11.7M Sell
278,732
-45,160
-14% -$1.74M 0.68% 41
2018
Q2
$11.1M Sell
323,892
-51,502
-14% -$1.76M 0.55% 50
2018
Q1
$12.6M Sell
375,394
-239,477
-39% -$8.23M 0.59% 49
2017
Q4
$21.1M Sell
614,871
-32,028
-5% -$1.09M 0.86% 37
2017
Q3
$21.9M Buy
646,899
+2,000
+0.3% +$64.3K 0.93% 36
2017
Q2
$20.6M Buy
644,899
+49,618
+8% +$1.56M 0.9% 35
2017
Q1
$19.3M Buy
595,281
+265,240
+80% +$8.36M 0.88% 39
2016
Q4
$19.1M Sell
330,041
-293,950
-47% -$8.97M 0.87% 36
2016
Q3
$20.1M Buy
623,991
+4,135
+0.7% +$138K 0.9% 38
2016
Q2
$20.7M Buy
619,856
+6,560
+1% +$209K 0.94% 35
2016
Q1
$17.2M Sell
613,296
-103,543
-14% -$2.96M 0.85% 40
2015
Q4
$22M Sell
716,839
-87,106
-11% -$2.74M 1.07% 38
2015
Q3
$24M Sell
803,945
-73,113
-8% -$2.34M 1.16% 37
2015
Q2
$27.9M Buy
+877,058
New +$28.6M 1.27% 27

Other funds holding PFE

Uniplan Investment Counsel's PFE Position: Q1 2020 in Review

Uniplan Investment Counsel sold out of Pfizer (PFE) in Q1 2020, closing a stake of 224,906 shares — an estimated $8.36M sold.

Uniplan Investment Counsel first reported a position in PFE in Q2 2015 and held it in 19 quarters. The position peaked at $27.9M in Q2 2015. 2,437 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

  • Uniplan Investment Counsel reported no remaining Pfizer position as of Q1 2020 after selling out during the quarter.
  • Uniplan Investment Counsel sold 224,906 Pfizer shares in Q1 2020, an estimated $8.36M.
  • Uniplan Investment Counsel first reported a position in Pfizer in Q2 2015 and held it in 19 quarters.
  • Uniplan Investment Counsel's Pfizer position peaked at $27.9M in Q2 2015.
  • 2,437 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on Uniplan Investment Counsel's 13F filing for Q1 2020, filed 15 May 2020.